Bartira Rossi-Bergmann Selected Research

Cutaneous Leishmaniasis

6/2021	MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis.
12/2020	Vitamin D increases killing of intracellular Leishmania amazonensis in vitro independently of macrophage oxidative mechanisms.
1/2020	Encapsulation in lipid-core nanocapsules improves topical treatment with the potent antileishmanial compound CH8.
1/2020	Single-dose treatment for cutaneous leishmaniasis with an easily synthesized chalcone entrapped in polymeric microparticles.
12/2019	Novel and safe single-dose treatment of cutaneous leishmaniasis with implantable amphotericin B-loaded microparticles.
1/2019	Nanoencapsulated retinoic acid as a safe tolerogenic adjuvant for intranasal vaccination against cutaneous leishmaniasis.
9/2018	Improved drug loading via spray drying of a chalcone implant for local treatment of cutaneous leishmaniasis.
1/2018	Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis.
1/2018	New chalcone compound as a promising antileishmanial drug for an old neglected disease: Biological evaluation using radiolabelled biodistribution.
1/2017	The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite control.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bartira Rossi-Bergmann Research Topics

Disease

26	Infections 01/2021 - 09/2003
21	Cutaneous Leishmaniasis 06/2021 - 09/2003
16	Leishmaniasis 11/2021 - 01/2004
8	Visceral Leishmaniasis (Kala Azar) 01/2022 - 03/2007
5	Hypersensitivity (Allergy) 08/2019 - 06/2009
2	Parasitic Diseases (Parasitic Disease) 01/2022 - 01/2020
2	Body Weight (Weight, Body) 03/2009 - 01/2004
1	Asthma (Bronchial Asthma) 07/2018
1	Neglected Diseases 01/2018
1	Inflammation (Inflammations) 01/2017
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2013
1	Proteinuria 01/2013
1	Neoplasms (Cancer) 06/2010
1	Necrosis 02/2007

Drug/Important Bio-Agent (IBA)

15	AntigensIBA 08/2019 - 09/2003
9	VaccinesIBA 01/2022 - 09/2003
7	Pharmaceutical PreparationsIBA 11/2021 - 01/2018
5	Chalcone (Benzalacetophenone)IBA 01/2020 - 01/2018
4	Messenger RNA (mRNA)IBA 01/2019 - 09/2011
4	DNA (Deoxyribonucleic Acid)IBA 10/2012 - 08/2004
3	Meglumine AntimoniateIBA 01/2021 - 01/2004
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2020 - 06/2010
2	CytokinesIBA 08/2019 - 01/2019
2	FlavonoidsIBA 07/2018 - 03/2009
2	Uridine Triphosphate (UTP)IBA 01/2018 - 09/2011
2	Interleukin-10 (Interleukin 10)IBA 01/2015 - 03/2007
2	Polymethyl Methacrylate (Sol)IBA 09/2014 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 10/2012
2	Serine (L-Serine)FDA Link 07/2010 - 09/2007
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2010 - 10/2005
2	AntibodiesIBA 11/2008 - 10/2005
2	Interleukin-4 (Interleukin 4)IBA 03/2007 - 02/2007
2	Interferon-gamma (Interferon, gamma)IBA 02/2007 - 09/2003
1	ChitosanIBA 01/2022
1	DNA VaccinesIBA 01/2022
1	Clemastine (Clemastine Fumarate)FDA LinkGeneric 01/2021
1	Antimicrobial PeptidesIBA 12/2020
1	Vitamin D FDA LinkGeneric 12/2020
1	ThioureaIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Cholecalciferol (Vitamin D3)FDA Link 01/2019
1	Antiparasitic Agents (Antiparasitics)IBA 10/2018
1	miltefosine (Impavido)IBA 10/2018
1	TeaIBA 07/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2018
1	Biological ProductsIBA 01/2018
1	InterleukinsIBA 01/2018
1	Purinergic P2X7 ReceptorsIBA 01/2017
1	Serine Proteases (Serine Protease)IBA 09/2014
1	ArginaseIBA 01/2013
1	ElectrolytesIBA 01/2013
1	Phosphotransferases (Kinase)IBA 10/2012
1	NucleotidesIBA 09/2011
1	Purinergic Receptors (Receptors, Purine)IBA 09/2011
1	LQB 118IBA 07/2011
1	NaphthoquinonesIBA 07/2011
1	Cysteine Proteinase InhibitorsIBA 07/2010
1	cyclopropapyrroloindoleIBA 07/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010
1	LatexIBA 06/2010
1	Adenosine Triphosphate (ATP)IBA 09/2009
1	lucifer yellowIBA 09/2009
1	Sunscreening Agents (Sunscreens)IBA 06/2009
1	quercitrinIBA 03/2009
1	GlycosidesIBA 03/2009
1	QuercetinIBA 03/2009
1	Cysteine Proteases (Cysteine Protease)IBA 11/2008
1	Peptides (Polypeptides)IBA 11/2008
1	PhenolsIBA 12/2007
1	LignansIBA 12/2007
1	Virulence Factors (Pathogenicity Factors)IBA 09/2007
1	Monoclonal AntibodiesIBA 03/2007
1	lipophosphonoglycanIBA 03/2007
1	Interleukin-12 (IL 12)IBA 02/2007
1	factor AIBA 02/2007
1	hydroxide ionIBA 04/2006
1	betadex (beta-cyclodextrin)IBA 01/2004
1	AntimonyIBA 01/2004

Therapy/Procedure

5	Injections 01/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 09/2018 - 01/2018
2	Therapeutics 01/2013 - 05/2007
1	Subcutaneous Injections 01/2018
1	Microspheres (Microsphere) 01/2018
1	Intralesional Injections 01/2018